US2015166598A1PendingUtilityA1

Steroids as Agonists for FXR

59
Assignee: INTERCEPT PHARMACEUTICALS INCPriority: Mar 12, 2001Filed: Feb 26, 2015Published: Jun 18, 2015
Est. expiryMar 12, 2021(expired)· nominal 20-yr term from priority
Inventors:Roberto Pellicciari
A61P 43/00A61P 3/06A61P 7/00A61P 9/00A61P 9/10A61P 1/16C07J 9/005C07J 43/00C07C 215/10C07C 215/08C07C 215/12C07J 9/00C07J 41/0055
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to compounds of formula (I): wherein R is ethyl, propyl or allyl, and pharmaceutically acceptable salts, solvates or amino acid conjugates thereof. The compounds of formula (I) are useful as FXR agonists.

Claims

exact text as granted — not AI-modified
What is claimed: 
     
         1 . A compound of formula I: 
       
         
           
           
               
               
           
         
       
       wherein R is ethyl or a pharmaceutically acceptable salt, solvate or amino acid conjugate thereof.

Join the waitlist — get patent alerts

Track US2015166598A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.